Could immune drugs help prevent miscarriages after IVF? new trial results awaited.
NCT ID NCT04701034
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a combination of intravenous immunoglobulin (IVIg) and prednisolone can increase the chance of a live birth in women who have had two or more unexplained miscarriages after fertility treatments like IVF. Eighty women were randomly assigned to receive either the active drugs or a placebo during early pregnancy. The goal was to see if calming the immune system could help more pregnancies survive past the first trimester.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FERTILITY DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
• The Centre for Recurrent Pregnancy Loss of Western Denmark, Department of Obstetrics and Gynaecology, Aalborg University Hospital
Aalborg, 9000, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a hormone blocker make miscarriage care more complete?
- Can a simple office procedure replace surgery for early miscarriage care?
- Immune protein G-CSF put to the test for unexplained recurrent miscarriage
- Could low egg count predict miscarriage? new study seeks answers
- New DNA tests could spot hidden chromosome flaws in infertility and developmental disorders
- Miscarriage care showdown: camera surgery vs suction – which works better?